ONC206 demonstrates potent antitumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma.
- DOI
- 10.1093/neuonc/noag053
- Published
- 2026 Jul 1
- Container
- Neuro-oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/neuonc/noag053,
title = {ONC206 demonstrates potent antitumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma.},
author = {Tzaridis T and Liu J and Chien FL and Malhotra A and Zhu D and Gershon I and Zhang H and Velazquez Vega JE and Schniederjan M and Sposito T and Adams PD and Allen JE and Prabhu VV and Wechsler-Reya RJ and MacDonald TJ},
year = {2026},
journal = {Neuro-oncology},
doi = {10.1093/neuonc/noag053},
url = {https://doi.org/10.1093/neuonc/noag053}
}RIS
TY - JOUR TI - ONC206 demonstrates potent antitumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma. AU - Tzaridis T AU - Liu J AU - Chien FL AU - Malhotra A AU - Zhu D AU - Gershon I AU - Zhang H AU - Velazquez Vega JE AU - Schniederjan M AU - Sposito T AU - Adams PD AU - Allen JE AU - Prabhu VV AU - Wechsler-Reya RJ AU - MacDonald TJ PY - 2026 JO - Neuro-oncology DO - 10.1093/neuonc/noag053 UR - https://doi.org/10.1093/neuonc/noag053 ER -
APA
T, T., J, L., FL, C., A, M., D, Z., I, G., H, Z., JE, V. V., M, S., T, S., PD, A., JE, A., VV, P., RJ, W., & TJ, M. (2026). ONC206 demonstrates potent antitumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma.. Neuro-oncology. https://doi.org/10.1093/neuonc/noag053
Source records
- pubmed · retrieved 2026-09-26T06:25:23.376Z